⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Bioequivalency Study of Exemestane 25 mg Tablet Under Fasted Conditions

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Bioequivalency Study of Exemestane 25 mg Tablet Under Fasted Conditions

Official Title: A Single Dose, 2-Period, 2-Treatment, 2-Way Bioequivalency Study of Exemestane 25 mg Tablets Under Fasting Conditions

Study ID: NCT01331421

Conditions

Breast Cancer

Interventions

exemestane

Study Description

Brief Summary: The objective of this study was to prove the bioequivalence of Exemestane 25 mg tablet under fasted conditions

Detailed Description:

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT

Sex: FEMALE

Healthy Volunteers: Yes

Locations

BioKinetic Clinical Applications, Inc., Springfield, Missouri, United States

Contact Details

Name: Dennis N Morrison, D.O.

Affiliation: Bio-Kinetic Clinical Applications, Inc.

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: